Skip to main content
Log in

Prevalence of legal and illegal stimulating agents in sports

  • Review
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

This paper reviews the prevalence of legal and illegal stimulants in relation to doping-control analysis. Stimulants are among the oldest classes of doping agents, having been used since ancient times. Despite the ease with which they can be detected and the availability of sensitive detection methods, stimulants are still popular among athletes. Indeed, they remain one of the top three most popular classes of prohibited substances. Because the list of legal and illegal stimulants is extensive only a selection is discussed in detail. The compounds selected are caffeine, ephedrines, amphetamine and related compounds, methylphenidate, cocaine, strychnine, modafinil, adrafinil, 4-methyl-2-hexaneamine, and sibutramine. These compounds are mainly prevalent in sport or are of therapeutic importance. Because stimulants are the oldest doping class the first detection methods were for this group. Several early detection techniques including GC–NPD, GC–ECD, and TLC are highlighted. The more novel detection techniques GC–MS and LC–MS are also discussed in detail. In particular, the last technique has been shown to enable successful detection of stimulants difficult to detect by GC–MS or for stimulants previously undetectable. Because stimulants are also regularly detected in nutritional (food) supplements a section on this topic is also included.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Delbeke FT (2000) Biol Sport 17(2):81–86

    Google Scholar 

  2. Van Wimersa Greidanus TB, Stoele F, Hartgens F (2000) In: Hartgens F, Kuipers H (eds) Bohn Stafleu–Van Loghum. België, Houten, p 3

    Google Scholar 

  3. Donohoe T, Johnson N (1986) Drug abuse in sports. Blackwell, Oxford

    Google Scholar 

  4. Verroken M (2000) Best Pract Res Clin Endocrinol Metab 14(1):1–23

    Article  CAS  Google Scholar 

  5. The 2010 Prohibited List, International Standard (2010) World Anti-Doping Agency. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2010_EN.pdf. Accessed 13.01.2011

  6. Docherty JR (2008) Br J Pharmacol 154(3):606–622

    Article  CAS  Google Scholar 

  7. Jones G (2008) Drugs and ergogenic aids to improve sport performance, vol 44. Essays in biochemistry. Portland Press Ltd, London, pp 109–123

    Google Scholar 

  8. Avois L, Robinson N, Saudan C, Baume N, Mangin P, Saugy M (2006) Br J Sports Med 40:16–20

    Article  Google Scholar 

  9. Van Eenoo P, Delbeke FT (2010) In: Thieme D, Hemmersbach P (eds) Handbook of experimental pharmacology. Springer-Verlag, Berlin, pp 227–249

    Google Scholar 

  10. Thevis M, Sigmund G, Geyer H, Schanzer W (2010) Endocrinol Metab Clin N Am 39(1):89–105

    Article  CAS  Google Scholar 

  11. Hemmersbach P, de la Torre R (1996) J Chromatogr B 687(1):221–238

    Article  CAS  Google Scholar 

  12. 2010 Prohibited List, Summary of Major Modifications (2010) World Anti-Doping Agency. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Summary_of_Modifications_2010_EN.pdf. Accessed 13.01.2011

  13. WADA (2009) 2009 adverse analytical findings and atypical findings reported by accredited laboratories. World Anti-Doping Agency, Montreal

    Google Scholar 

  14. 2009 Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories (2009) World Anti-Doping Agency. http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/Lab_Statistics/WADA_2009_LaboratoryStatisticsReport_Final.pdf. Accessed 13.01.2011

  15. 2008 Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories (2008) World Anti-Doping Agency. http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/WADA_LaboStatistics_2008.pdf. Accessed 13.01.2011

  16. Deventer K, Van Eenoo P, Baele G, Pozo OJ, Van Thuyne W, Delbeke FT (2009) Drug Test Anal 1(5–6):209–213

    Article  CAS  Google Scholar 

  17. Graham T (1998) News on sport nutrition: insider 6(2):1–7

    Google Scholar 

  18. Anselme F, Collomp K, Mercier B, Ahmaidi S, Prefaut C (1992) Eur J Appl Physiol Occup Physiol 65(2):188–191

    Article  CAS  Google Scholar 

  19. Collomp K, Ahmaidi S, Chatard JC, Audran M, Prefaut C (1992) Eur J Appl Physiol Occup Physiol 64(4):377–380

    Article  CAS  Google Scholar 

  20. Graham TE, Rush JWE, Vansoeren MH (1994) Can J Appl Physiol 19(2):111–138

    Article  CAS  Google Scholar 

  21. Greer F, McLean C, Graham TE (1998) J Appl Physiol 85(4):1502–1508

    CAS  Google Scholar 

  22. Sinclair CJD, Geiger JD (2000) J Sport Med Phys Fit 40(1):71–79

    CAS  Google Scholar 

  23. Tarnopolsky MA (1994) Sports Med 18(2):109–125

    Article  CAS  Google Scholar 

  24. Graham TE, Spriet LL (1995) J Appl Physiol 78(3):867–874

    CAS  Google Scholar 

  25. Kovacs EMR, Stegen JHCH, Brouns F (1998) J Appl Physiol 85(2):709–715

    CAS  Google Scholar 

  26. Van Thuyne W, Delbeke FT (2006) Int J Sports Med 27(9):745–750

    Article  CAS  Google Scholar 

  27. Van Thuyne W, Roels K, Delbeke FT (2005) Int J Sports Med 26(9):714–718

    Article  CAS  Google Scholar 

  28. Bell DG, McLellan TM, Sabiston CM (2002) Med Sci Sports Exerc 34(2):344–349

    Article  CAS  Google Scholar 

  29. Bouchard R, Weber AR, Geiger JD (2002) Clin J Sport Med 12(4):209–224

    Article  Google Scholar 

  30. Jacobs I, Pasternak H, Bell DG (2003) Med Sci Sports Exerc 35(6):987–994

    Article  CAS  Google Scholar 

  31. Gill ND, Shield A, Blazevich AJ, Zhou S, Weatherby RP (2000) Br J Clin Pharmacol 50(3):205–213

    Article  CAS  Google Scholar 

  32. Chester N, Reilly T, Mottram DR (2003) Int J Sports Med 24(1):3–8

    Article  CAS  Google Scholar 

  33. Hodges K, Hancock S, Currell K, Hamilton B, Jeukendrup AE (2006) Med Sci Sports Exerc 38(2):329–333

    Article  Google Scholar 

  34. Chu KS, Doherty TJ, Parise G, Milheiro JS, Tarnopolsky MA (2002) Clin J Sport Med 12(6):387–390

    Article  Google Scholar 

  35. Gillies H, Derman WE, Noakes TD, Smith P, Evans A, Gabriels G (1996) J Appl Physiol 81(6):2611–2617

    CAS  Google Scholar 

  36. Jones G (2008) In: Cooper CE, Beneke R (eds) Essays in biochemistry, volume 44: drugs and ergogenic aids to improve sport performance, vol 44. Portland Press, London, pp 109–123

    Google Scholar 

  37. Pokrywka A, Tszyrsznic W, Kwiatkowska DJ (2009) Int J Sports Med 30(8):569–572

    Article  CAS  Google Scholar 

  38. Strano-Rossi S, Leone D, de la Torre X, Botre F (2009) Ther Drug Monit 31(4):520–526

    Article  CAS  Google Scholar 

  39. van der Merwe PJ, Brown LW, Hendrikz SE (1994) J Chromatogr 661(2):357–361

    Article  Google Scholar 

  40. Van Eenoo P, Delbeke FT, Roels K, De Backer P (2001) J Chromatogr B 760(2):255–261

    Article  Google Scholar 

  41. Spyridaki MHE, Tsitsimpikou CJ, Siskos PA, Georgakopoulos CG (2001) J Chromatogr B 758(2):311–314

    Article  CAS  Google Scholar 

  42. Gmeiner G, Geisendorfer T, Kainzbauer J, Nikolajevic M, Tausch H (2002) J Chromatogr B 768(2):215–221

    Article  CAS  Google Scholar 

  43. Thevis M, Schanzer W (2005) J Chromatogr Sci 43(1):22–31

    CAS  Google Scholar 

  44. Spyridaki M-H, Kiousi P, Vonaparti A, Valavani P, Zonaras V, Zahariou M, Sianos E, Tsoupras G, Georgakopoulos C (2006) Anal Chim Acta 573:242–249

    Article  CAS  Google Scholar 

  45. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT (2009) J Chromatogr B 877:369–374

    Article  CAS  Google Scholar 

  46. Edeleano L (1887) Ber Deutsch Chem Ges 20(1):616–622

    Article  Google Scholar 

  47. Rang HP, Dale MM, Ritter JM (1995) Pharmacology, 3e Edition edn. Churchill Livingstone, New York

    Google Scholar 

  48. Kraemer T, Maurer HH (2002) Ther Drug Monit 24(2):277–289

    Article  CAS  Google Scholar 

  49. Polgar M, Vereczkey L, Szporny L, Czira G, Tamas J, Gacsbaitz E, Holly S (1979) Xenobiotica 9(8):511–519

    Article  CAS  Google Scholar 

  50. Gomez C, Segura J, Monfort N, Suominen T, Leinonen A, Vahermo M, Yli-Kauhaluoma J, Ventura R (2010) Anal Bioanal Chem 397(7):2903–2916

    Article  CAS  Google Scholar 

  51. Appolonova SA, Shpak AV, Semenov VA (2004) J Chromatogr B 800(1–2):281–289

    Article  CAS  Google Scholar 

  52. Logan B (2002) Forensic Sci Rev 14:410–416

    Google Scholar 

  53. Delbeke FT, Debackere M (1975) J Chromatogr 106(2):412–417

    Article  CAS  Google Scholar 

  54. Redalieu E (1982) Drug Metab Dispos 10(6):708–709

    CAS  Google Scholar 

  55. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT (2009) J Chromatogr A 1216(31):5819–5827

    Article  CAS  Google Scholar 

  56. Solans A, Carnicero M, Delatorre R, Segura J (1994) J Chromatogr B 658(2):380–384

    Article  CAS  Google Scholar 

  57. Ventura R, Roig M, Monfort N, Saez P, Berges R, Segura J (2008) Eur J Mass Spectrom 14(3):191–200

    Article  CAS  Google Scholar 

  58. Mazzarino M, de la Torre X, Botre F (2008) Anal Bioanal Chem 392(4):681–698

    Article  CAS  Google Scholar 

  59. Eichhorst J, Etter M, Lepage J, Lehotay DC (2004) Clin Biochem 37(3):175–183

    Article  CAS  Google Scholar 

  60. Badoud F, Grata E, Perrenoud L, Avois L, Saugy M, Rudaz S, Veuthey JL (2009) J Chromatogr A 1216(20):4423–4433

    Article  CAS  Google Scholar 

  61. Badoud F, Grata E, Perrenoud L, Saugy M, Rudaz S, Veuthey JL (2009) J Chromatogr A 1217(25):4109–4119

    Article  CAS  Google Scholar 

  62. Thorngren JO, Ostervall F, Garle M (2008) J Mass Spectrom 43(7):980–992

    Article  CAS  Google Scholar 

  63. Technical Document: Minimum Required Performance Limits for Detection of Prohibited Substances: TD2010MRPL (2010) WADA (World Anti-Doping Agency). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/WADA_TD2010MRPLv1.0_Minimum%20Required%20Performance%20Levels_Sept%2001%202010_EN.pdf. Accessed 13.01.2011

  64. Ramcharitar V, Levine B, Smialek JE (1995) J Forensic Sci 40(1):99–101

    CAS  Google Scholar 

  65. Van Eenoo P, Deventer K, Roels K, Delbeke FT (2006) Forensic Sci Int 164(2–3):159–163

    Google Scholar 

  66. Strano-Rossi S, Molaioni F, Rossi F, Botre F (2005) Rapid Commun Mass Spectrom 19(11):1529–1535

    Article  CAS  Google Scholar 

  67. Van Thuyne W, Van Eenoo P, Delbeke FT (2007) J Chromatogr B 857(2):259–265

    Article  CAS  Google Scholar 

  68. Tseng YL, Uralets V, Lin CT, Kuo FH (2005) J Pharm Biomed Anal 39(5):1042–1045

    Article  CAS  Google Scholar 

  69. Lopez FA (2006) J Dev Behav Pediatr 27(5):410–416

    Article  Google Scholar 

  70. Kaufman KR, Gerner R (2005) Br J Sports Med 39(4):241–244

    Article  CAS  Google Scholar 

  71. Hatton CK (2007) Pediatr Clin N Am 54 (4):713–733

    Google Scholar 

  72. Rao RN, Shinde DD, Talluri M, Agawane SB (2008) J Chromatogr B 873(1):119–123

    Article  CAS  Google Scholar 

  73. Lu JH, Wang XB, Yang SM, Liu X, Qin Y, Shen L, Wu Y, Xu YX, Wu MT, Ouyang GF (2009) Rapid Commun Mass Spectrom 23(11):1592–1600

    Article  CAS  Google Scholar 

  74. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT (2008) LC–GC N Am 26 (4):376–389

    Google Scholar 

  75. The 2007 Prohibited List, International Standard (2007) World Anti-Doping Agency. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2007_EN.pdf. Accessed 13.01.2011

  76. Perrenoud L, Saugy M, Saudan C (2009) J Chromatogr B 877(29):3767–3770

    Article  CAS  Google Scholar 

  77. Geyer H, Parr MK, Koehler K, Mareck U, Schanzer W, Thevis M (2008) J Mass Spectrom 43(7):892–902

    Article  CAS  Google Scholar 

  78. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC (1998) Int J Obes 22:S18–S28

    CAS  Google Scholar 

  79. McNeely W, Goa KL (1998) Drugs 56(6):1093–1124

    Article  CAS  Google Scholar 

  80. King DJ, Devaney N (1988) Br J Clin Pharmacol 26(5):607–611

    CAS  Google Scholar 

  81. Glick SD, Haskew RE, Maisonneuve IM, Carlson JN, Jerussi TP (2000) Eur J Pharmacol 397(1):93–102

    Article  CAS  Google Scholar 

  82. Sardela VF, Motta MTR, Padilha MC, Pereira HMG, Neto FRA (2009) J Chromatogr B 877(27):3003–3011

    Article  CAS  Google Scholar 

  83. Strano-Rossi S, Colamonici C, Botre F (2007) Rapid Commun Mass Spectrom 21(2):79–88

    Article  CAS  Google Scholar 

  84. Thevis M, Sigmund G, Schiffer AK, Schnazer W (2006) Eur J Mass Spectrom 12(2):129–136

    Article  CAS  Google Scholar 

  85. Meyer MR, Maurer HH (2010) Curr Drug Metab 11(5):468–482

    Article  CAS  Google Scholar 

  86. Gibbons S, Zloh M Bioorg Med Chem Lett 20 (14):4135–4139

  87. Archer RP (2009) Forensic Sci Int 185(1–3):10–20

    Article  CAS  Google Scholar 

  88. Rosner P, Quednow B, Girreser U, Junge T (2005) Forensic Sci Int 148(2–3):143–156

    Article  CAS  Google Scholar 

  89. Torrance H, Cooper G (2010) Forensic Sci Int 202(1–3):E62–E63

    Article  CAS  Google Scholar 

  90. Mephedrone report (2009) Institute of Psychiatry, King's College, London. http://194.83.136.209/documents/reports/Mephedrone.pdf. Accessed 17.01.2011

  91. de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clin Pharmacokinet 43(3):157–185

    Article  Google Scholar 

  92. Beckett AH, Moffat AC (1968) J Pharm Pharmacol S 20:S48–S50

    Google Scholar 

  93. Beckett AH, Tucker GT, Moffat AC (1967) J Pharm Pharmacol 19(5):273–294

    Google Scholar 

  94. Donike M, Jaenicke L, Stratman.D, Hollmann W (1970) J Chromatogr 52(2):237–250

    Google Scholar 

  95. Donike M (1973) J Chromatogr 78(2):273–279

    CAS  Google Scholar 

  96. Delbeke FT, Debackere M (1978) J Chromatogr 161(NOV):360–365

    Article  CAS  Google Scholar 

  97. Delbeke FT, Debackere M (1977) J Chromatogr 133(1):214–217

    Article  CAS  Google Scholar 

  98. Delbeke FT, Debackere M (1977) J Chromatogr 136(3):385–390

    Article  CAS  Google Scholar 

  99. Kraemer T, Maurer HH (1998) J Chromatogr B 713(1):163–187

    Article  CAS  Google Scholar 

  100. Rossi SS, de la Torre X, Botre F (2010) Rapid Commun Mass Spectrom 24(10):1475–1480

    Article  CAS  Google Scholar 

  101. Maurer HH (1998) J Chromatogr B 713(1):3–25

    Article  CAS  Google Scholar 

  102. Thieme D, Sachs H (2003) Anal Chim Acta 492(1–2):171–186

    Article  CAS  Google Scholar 

  103. Goebel C, Trout GJ, Kazlauskas R (2004) Anal Chim Acta 502(1):65–74

    Article  CAS  Google Scholar 

  104. Deventer K, Van Eenoo P, Delbeke FT (2005) Rapid Commun Mass Spectrom 19(2):90–98

    Article  CAS  Google Scholar 

  105. Maurer HH (2006) J Mass Spectrom 41(11):1399–1413

    Article  CAS  Google Scholar 

  106. Thevis M, Schanzer W (2007) Anal Bioanal Chem 388(7):1351–1358

    Article  CAS  Google Scholar 

  107. Hemmersbach P (2008) J Mass Spectrom 43(7):839–853

    Article  CAS  Google Scholar 

  108. Bowers LD (2009) Ann Rev Anal Chem 2:485–507

    Article  CAS  Google Scholar 

  109. Deventer K, Van Eenoo P, Delbeke FT (2006) Rapid Commun Mass Spectrom 20(5):877–882

    Article  CAS  Google Scholar 

  110. Lu JH, Wang S, Dong Y, Wang XB, Yang SM, Zhang JL, Deng J, Qin Y, Xu YX, Wu M, Ouyang GF (2010) Anal Chim Acta 657(1):45–52

    Article  CAS  Google Scholar 

  111. Thomas A, Sigmund G, Guddat S, Schanzer W, Thevis M (2008) Eur J Mass Spectrom 14(3):135–143

    Article  CAS  Google Scholar 

  112. Peters RJB, Oosterink JE, Stolker AAM, Georgakopoulos C, Nielen MWF (2010) Anal Bioanal Chem 396(7):2583–2598

    Article  CAS  Google Scholar 

  113. Vonaparti A, Lyris E, Angelis YS, Panderi I, Koupparis M, Tsantili-Kakoulidou A, Peters RJB, Nielen MWF, Georgakopoulos C (2010) Rapid Commun Mass Spectrom 24(11):1595–1609

    Article  CAS  Google Scholar 

  114. Dikunets MA, Appolonova SA, Rodchenkov GM (2009) J Anal Chem 64(8):832–842

    Article  CAS  Google Scholar 

  115. Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Ojanpera I (2009) Drug Test Anal 1(5–6):250–266

    Article  CAS  Google Scholar 

  116. Murray GJ, Danaceau JP (2009) J Chromatogr B 877(30):3857–3864

    Article  CAS  Google Scholar 

  117. Kolmonen M, Leinonen A, Pelander A, Ojanpera I (2007) Anal Chim Acta 585(1):94–102

    Article  CAS  Google Scholar 

  118. Davies AM (1997) Food Surveill 103:1–18

    Google Scholar 

  119. Abourashed EA, El-Alfy AT, Khan IA, Walker L (2003) Phytother Res 17(7):703–712

    Article  CAS  Google Scholar 

  120. Gurley BJ, Wang P, Gardner SF (1998) J Pharm Sci 87(12):1547–1553

    Article  CAS  Google Scholar 

  121. Delbeke FT (2001) In: Peters C, Schulz T, Michna H (eds) Biomedical Side Effects of Doping, vol 13. Sport & Buch Strauß, Cologne (Germany), pp 155–161

  122. de Hon O, Coumans B (2007) Br J Sports Med 41(11):800–805, discussion 805

    Article  Google Scholar 

  123. Turner M, McCrory P, Johnston A (2005) Br J Pharmacol 39 (10):e37

    Google Scholar 

  124. Parr MK, Geyer H, Sigmund G, Köhler K, Schänzer W (2003) In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis, vol 11. Sport & Buch Strauß, Cologne (Germany), pp 67–75

  125. Nederlands Zekerheidssysteem Voedingssupplementen Topsport—NZVT (2003) http://www.necedo.nl/nzvt/thenetherlandssecuritysystemnutritionalsupplements. Accessed 13.01.2011

  126. Deventer K, Van Thuyne W, Mikulcikova P, Van Eenoo P, Delbeke FT (2007) 103(4):1508–1513

Download references

Acknowledgements

The authors would like to thank Lance Brooker for correcting the language in the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Deventer.

Additional information

Published in the special issue Anti-Doping Analysis with Guest Editor Mario Thevis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deventer, K., Roels, K., Delbeke, F.T. et al. Prevalence of legal and illegal stimulating agents in sports. Anal Bioanal Chem 401, 421–432 (2011). https://doi.org/10.1007/s00216-011-4863-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-011-4863-0

Keywords

Navigation